Management and Prevention of Bone Complications Supportive Care

Denosumab Effective in Patients with Bone Metastases (08-7-2009)

Among patients with bone metastases from cancers other than breast cancer or prostate cancer, the investigational drug denosumab was as effective as Zometa® (zoledronic acid) at reducing the risk of bone complications such as fracture. The results of... Continue Reading

Denosumab More Effective than Zometa® in Patients with Bone Metastases (07-9-2009)

Among women with bone metastases from breast cancer, the investigational drug denosumab was more effective than Zometa® (zoledronic acid) at reducing the risk of bone complications such as fracture. The results of this Phase III clinical trial were made... Continue Reading

« Previous Page